Fig. 4: Clinical outcomes of 10 SZ patients and 12 SZ+ patients at 12 months following gene-targeted management. | European Journal of Human Genetics

Fig. 4: Clinical outcomes of 10 SZ patients and 12 SZ+ patients at 12 months following gene-targeted management.

From: Impact of rapid genomic testing on clinical outcomes of acutely unwell children presenting with severe epilepsy

Fig. 4

The light green bar indicates seizure stopped; the light purple bar indicates seizures continued with a 50% reduction; the light blue bar indicates seizures continued; the dark green and purple bar shows the number deceased and lost to follow-up, respectively.

Back to article page